Search

Search Constraints

You searched for: Author/Creator Santamaría, Amparo

Search Results

2. Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis. (October 2019)

3. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. (December 2022)

4. Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish population. (18th January 2019)

5. Is there a procoagulant state long-term after lung transplantation? A prospective study. (November 2021)

6. Prophylaxis with enoxaparin for prevention of venous thromboembolism after lung transplantation: a retrospective study. (7th September 2017)

7. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Issue 1 (January 2020)

8. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation. (4th June 2020)

10. Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system. Issue 3 (23rd February 2021)